KB
TMO icon

Kimelman & Baird’s Thermo Fisher Scientific TMO Stock Holding History

Kimelman & Baird’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2
Closed -$971 – 303
2025
Q3 		$971 Hold
2
– – ﹤0.01% 280
2025
Q2 		$811 Hold
2
– – ﹤0.01% 309
2025
Q1 		$996 Hold
2
– – ﹤0.01% 301
2024
Q4 		$1.04K Hold
2
– – ﹤0.01% 309
2024
Q3 		$1.24K Hold
2
– – ﹤0.01% 308
2024
Q2 		$1.11K Buy
+2
New +$1.15K ﹤0.01% 318

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kimelman & Baird's TMO Position: Q4 2025 in Review

Kimelman & Baird sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 2 shares — an estimated $971 sold.

Kimelman & Baird first reported a position in TMO in Q2 2024 and held it in 6 quarters. The position peaked at $1.24K in Q3 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Kimelman & Baird reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Kimelman & Baird sold 2 Thermo Fisher Scientific shares in Q4 2025, an estimated $971.
  • Kimelman & Baird first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 6 quarters.
  • Kimelman & Baird's Thermo Fisher Scientific position peaked at $1.24K in Q3 2024.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Kimelman & Baird's 13F filing for Q4 2025, filed 6 Feb 2026.